Bernie Sanders Heads to Canada to Highlight the U.S. Pharmaceutical Industry’s Corruption
The presidential candidate travels with a caravan of type 1 diabetes patients seeking affordable insulin in America's northern neighbor.
On a bus headed toward Canada, the Democrat discusses insulin with Americans seeking more affordable medicine. (Instagram)
Presidential candidate Senator Bernie Sanders is heading to Canada on Sunday with a caravan of Type 1 diabetes patients seeking cheaper insulin to highlight the “corruption” of pharmaceutical companies and the toll taken on Americans who can’t afford the medicine.
CTV News reported:
(Sanders) waved to crowds as he entered the Olde Walkerville Pharmacy in Windsor, Ont. on Sunday.
Sanders stood next to a mother who said she spends roughly US $1,500 a month for insulin for her son. But in Windsor, she paid US $1,000 for a six-month supply.
A vial of insulin which Type 1 diabetics use to regulate their blood sugar costs about US $340 in the United States — roughly 10 times the Canadian price. An American Diabetes Association spokesperson previously told CTVNews.ca the average price of insulin has nearly tripled between 2002 and 2013.
“People are dying,” Sanders earlier told CNN’s Jake Tapper on “State of the Union,” in an interview hosted from Detroit, Michigan. He said the cost of insulin in the US has “soared in recent years” and “there is strong evidence that there is price fixing, that these companies simultaneously raise the prices at outrageous levels far, far, far more than the cost of production.”
He accused drug company executives of “corruption” and “unbelievable greed.” In Canada, he said, insulin is “one-tenth of the price.”
“One out of four people are rationing their insulin, and people are dying. That is unacceptable in the United States of America,” he claims.
Sanders said if elected president, “we’re going to take on the pharmaceutical industry, we’re going to have an attorney general who is going to deal with the incredible concentration of ownership and we’re going to use anti-trust legislation.”
“Three drug companies made $14.5 billion in profit last year, control 90% of the insulin in this country, it’s just an amazing coincidence prices go up and and up and up, so what you do is you throw these people in jail if they engage in price fixing” @BernieSanders #Insulin4all pic.twitter.com/Upaqe18gam
— People for Bernie (@People4Bernie) July 28, 2019
Your support matters…Traveling to ?? today w/ @SenSanders and a group of ppl w/ type 1 diabetes who desperately need affordable insulin. For the Sen. to come w/ us is huge, bc it will raise the profile of this crisis worldwide, and that’s what it desperately needs.Follow along! #insulin4all pic.twitter.com/mSG19FLnTv
— Quinn Nystrom (@QuinnNystrom) July 28, 2019
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Opinion
The HHS nominee is right to target a system that overpays specialists and leaves the rest of us footing the bill.
Economic Justice
In the absence of patents, it would be rare that a drug would sell for more than $30 a prescription.
Opinion
Import taxes have nothing on drug patents that raise prices 100-fold.
Opinion
The opioid epidemic would not have been possible without the cooperation of the House of Medicine, from leading journals to the AMA.
Editorial Cartoons
Health & Wellness
The University of California’s Opioid Industry Documents Archive opens new windows onto the institutional sociopathy behind the opioid crisis.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.